氧化低密度脂蛋白的临床意义与检测方法的新进展
被引量:5
出处
《临床检验杂志》
CAS
CSCD
北大核心
2009年第2期151-154,共4页
Chinese Journal of Clinical Laboratory Science
基金
南京军区"十一五"医药卫生科研基金资助项目(批准号06MA130)
参考文献24
-
1汪俊军.血浆氧化LDL水平与动脉粥样硬化的关系[J].临床检验杂志,2003,21(1):48-50. 被引量:28
-
2Nishi K, Itabe H, Uno M, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability [ J ]. Arterioscler Thromb Vasc Biol,2002,22 ( 10 ) : 1649-1654.
-
3Naruko T, Ueda M, Ehara S, et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis [ J ]. Arterioscler Thromb Vasc Biol, 2006,26 ( 4 ) : 877-883.
-
4Uno M,Kitazato K T,Nishi K,et al. Raised plasma oxidised LDL in acute cerebral infarction [ J ]. J Neurol Neurosurg Psychiatry, 2003,74 (3) :312-316.
-
5Segev A,Strauss B H,Witztum J L,et al. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina[ J ]. Am Heart J ,2005,150 (5) : 1007-1014.
-
6Matsuura E, Hughes G R, Khamashta M A. Oxidation of LDL and its clinical implication [ J ]. Autoimmunity Reviews ,2008,7:558-566.
-
7汪俊军,李雯,刘恋,周毓,张春妮,范乐明.氧化低密度脂蛋白循环免疫复合物诱导巨噬细胞胆固醇酯蓄积[J].医学研究生学报,2005,18(3):193-195. 被引量:17
-
8陈玉成,梁玉佳,刘瑞,黄明慧,曾智.氧化低密度脂蛋白对血管内皮细胞骨架的损伤及其机制[J].心血管康复医学杂志,2004,13(4):320-321. 被引量:41
-
9Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified [ J ]. Biol Pharm Bull,2003,26 (1) :1-9.
-
10Binder C J, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation:molecular mimicry between Streptococcus pneumoniae and oxidized LDL [ J ]. Nat Med, 2003,9 : 736-743.
二级参考文献53
-
1汪俊军,李雯,刘恋,周毓,张春妮,范乐明.氧化低密度脂蛋白循环免疫复合物诱导巨噬细胞胆固醇酯蓄积[J].医学研究生学报,2005,18(3):193-195. 被引量:17
-
2[1]Witztum J L, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis[J]. J Clin Invest, 1991, 88(6)∶1785-1792.
-
3[2]Hovoet P, Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis[J]. Atherosclerosis,1998,137(Suppl)∶33-38.
-
4[3]Ehara S, Ueda M, Naruko T,et al.Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes[J]. Circulation, 2001;103(15)∶1955-1960.
-
5[4]Smith C, Mitchinson M J, Aruoma O I,et al.Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions[J]. J Biochem,1992,286(3)∶901-905.
-
6[5]Van der Wal A C, Becker A E, van der Loos C M,et al.Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology [J]. Circulation,1994,89(1)∶36-44.
-
7[6]Hiltunen T P, Yl-Herttuala S. Expression of lipoprotein receptors in atherosclerotic lesions[J]. Atherosclerosis,1998,137(Suppl)∶81-88.
-
8[7]Kaartinen M, Penttil A, Kovanen P T.Extracelluar mast cell granules carry apolipoprotein B-100-containing lipoproteins into phagocytes in human arterial initima. Functional coupling of exocytosis and phagocytosis in neighboring cells[J].Arterioscler Thromb Vasc Biol,1995,15(11)∶2047-2054.
-
9[8]Yl-Herttuala S, Palinski W, Rosenfeld M E,et al. Evidence for the presence of modified low density lipoprotein in atherosclerotic lesions of rabbit and man[J].J Clin Invest,1989,84(4)∶1086-1095.
-
10[9]Boyd H C, Gown A M, Wolfbauer G,et al.Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modiified LDL in atherosclerotic lesions from a Watanbe heritable hyperlipidemic rabbit[J]. Am J Pathol, 1989,135(5)∶815-825.
共引文献85
-
1夏琛,崔心禹,项婷,樊永康,沈建福.棕榈油酸功能的研究进展[J].中国油脂,2020,45(2):39-43. 被引量:22
-
2汪俊军,张春妮,庄一义.低密度脂蛋白亚组分不同特性在动脉粥样硬化中的作用[J].中国动脉硬化杂志,2004,12(2):227-228. 被引量:15
-
3于立宏,田刚,王金良.氧化低密度脂蛋白与2型糖尿病动脉粥样硬化关系的探讨[J].天津医科大学学报,2004,10(2):248-250. 被引量:1
-
4胡兵,汪俊军,张春妮,蔡辉.血浆氧化型低密度脂蛋白水平与低密度脂蛋白循环免疫复合物的相关性[J].中国动脉硬化杂志,2003,11(7):639-642. 被引量:1
-
5王绍栋.氧化型低密度脂蛋白与冠状动脉病变程度的关系[J].江西医学检验,2005,23(1):44-45.
-
6汪俊军,顾振华,张春妮,范乐明.脂蛋白(a)氧化和自身免疫与动脉粥样硬化的关系[J].医学研究生学报,2005,18(8):740-742. 被引量:22
-
7翁国路.氧化型低密度脂蛋白测定在冠状动脉病变中的意义[J].潍坊医学院学报,2005,27(4):298-299.
-
8汪俊军,顾振华,李雯,刘恋,张春妮,范乐明.脂蛋白(a)循环免疫复合物诱导巨噬细胞胆固醇酯蓄积[J].中华检验医学杂志,2005,28(11):1185-1188. 被引量:9
-
9莫中成,易光辉,陈欣,唐朝克,王佐,刘录山,杨永宗.氧化低密度脂蛋白对THP-1巨噬细胞CD36表达的影响[J].医学研究生学报,2006,19(1):6-9. 被引量:11
-
10汪俊军,朱雁飞,强红娟,张春妮.人血清氧化低密度脂蛋白自身抗体的提取和初步鉴定[J].临床检验杂志,2006,24(1):4-6. 被引量:2
同被引文献31
-
1张丽伟,翟桂兰.牛磺酸抗动脉粥样硬化作用研究进展[J].心血管病学进展,2006,27(4):512-514. 被引量:4
-
2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15807
-
3何喜民,向定成,何建新,洪长江,邱健,马骏,张金霞.不同类型心绞痛患者低密度脂蛋白及氧化型低密度脂蛋白的比较研究[J].中华心血管病杂志,2007,35(5):451-454. 被引量:8
-
4Teruyoshi Yanagita,Seo-Young Han,Ying Hu,et al.Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells[J].Lipids in Health and Disease,2008,7(1):38.
-
5Xu J,Arneja AS,Tappia PS,et al.The potential health benefits of taurine in cardiovascular disease[J].Experimental & Clinical Cardiology,2008,13(2):57.
-
6Najarian RM, Sullivan LM, Kannel WB, et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke : the Framing- ham offspring study [J]. Arch Intern Med,2006 ; 166 ( 1 ) : 106-11.
-
7Hamann Gf. Unriddling the role of matrix metalloproteinases in human cerebral stroke[J]. Stroke ,2003 ;34( 1 ) :40-6.
-
8陈伟伟,杜万良.中国心血管病报告2014[R]. 北京:中国大百科 全书出版社,2014.
-
9Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals[J]. Circ Res, 2007,101(1):27-39.
-
10Libby P.Inflammation and atherosclerosis[J].Circulation, 2002,105(9):135-143.
引证文献5
-
1袁吉祥,姚成立.牛磺酸拮抗高脂血症致兔动脉粥样硬化的实验研究[J].吉林医学,2010,31(31):5498-5500. 被引量:1
-
2马瑞,付英,杜继臣,李继来,王培福.普罗布考对脑梗死急性期伴代谢综合征患者血清氧化型低密度脂蛋白水平的影响[J].中国老年学杂志,2012,32(11):2264-2265. 被引量:1
-
3吴玉婷,孙云,刘国栋.甘草总黄酮对高脂血症模型小鼠的干预作用[J].黑龙江医药,2013,26(5):774-777. 被引量:8
-
4吴建榕,马奕晶,马春梅.建立北京健康人血浆髓过氧化物酶参考值和氧化低密度脂蛋白、脂蛋白磷脂酶参考区间[J].中华临床实验室管理电子杂志,2016,4(2):116-121. 被引量:3
-
5温文慧,匡泽民,王绿娅.重新认识脂蛋白(a)促进动脉粥样硬化性心血管疾病的作用[J].临床检验杂志,2018,36(3):190-192. 被引量:9
二级引证文献22
-
1孙懿,刘惠兰.不同透析膜对凝血纤溶系统的影响[J].国外医学(泌尿系统分册),2000,20(2):89-92. 被引量:2
-
2吴志勇,颜光烈,浦晓东,陈诗泉.定位性兔髂动脉粥样硬化模型的建立[J].吉林医学,2014,35(19):4137-4140.
-
3徐学君,张秀芳,徐德琴,程幼苗.黄酮类化合物调节血脂作用的研究进展[J].中国药房,2016,27(1):114-117. 被引量:43
-
4李娜,张新庄,王俨如,曹亮,丁岗,王振中,萧伟,徐筱杰.基于网络药理学方法探讨通塞脉片治疗动脉粥样硬化的作用机制[J].中国中药杂志,2016,41(9):1706-1712. 被引量:19
-
5雒刚刚,路芳,乔连生,李勇,张燕玲.基于分子模拟技术筛选LXRβ中药激动剂[J].中国中药杂志,2016,41(16):3065-3071. 被引量:5
-
6马文娟,杨佳,赵世刚.普罗布考联合阿托伐他汀对脑梗死患者血清hs-CRP ox-LDL MMP-9水平及颈动脉斑块的影响[J].河北医学,2017,23(4):620-623. 被引量:17
-
7侯腾飞,陈媛媛,张群群,孙爱萍,陈雅慧,孙洪胜.3类16味临床常用抗动脉粥样硬化中药的作用机制研究[J].中国药房,2018,29(17):2432-2438. 被引量:26
-
8李静,周麟.阿替普酶溶栓联合阿司匹林、氯吡格雷、依诺肝素治疗STEMI的疗效及其对患者血清NT-proBNP、Lp(a)、β2M水平的影响[J].中国医学前沿杂志(电子版),2019,11(6):43-47. 被引量:2
-
9胡超群,周继栋,傅旎旎,薛慧文,李鑫飞,赵启韬.中药防治动脉粥样硬化有效成分及作用机制研究进展[J].山东中医杂志,2019,38(11):1078-1081. 被引量:4
-
10李名鹏,史廷枫,郭子安,郭满容,王仲华.冠心病患者血清Lp(a)、NEFA水平变化及临床意义[J].中国医药导报,2020,17(2):61-64. 被引量:15
-
1张玮玮.氧化修饰低密度脂蛋白的特点和检测方法及临床意义[J].中国误诊学杂志,2004,4(3):367-369. 被引量:4
-
2陈琪,陈丙莺,陈秀英,王南.血清氧化性修饰载脂蛋白B的新法测定[J].南京医科大学学报(自然科学版),1996,16(5):414-416.
-
3庞海燕,陈小丽,邓改芳.化疗并发症的护理[J].家庭护士(专业版),2008,6(27):2498-2498.
-
4王保云.化疗病人恶心呕吐的临床护理[J].航空航天医学杂志,2011,22(4):493-494.
-
5魏兰英.肿瘤病人化疗的护理[J].中外医学研究,2009,7(6):81-81.
-
6李根娣.恶性肿瘤病人化疗的护理[J].实用临床医学(江西),2002,3(4):116-116. 被引量:2
-
7王玉珍,赵君庸.脂质过氧化产物检测方法概述[J].陕西医学检验,1998,13(2):62-62.
-
8李小青.肿瘤化疗患者的舒适护理[J].医学信息(中旬刊),2010,5(4):900-901.
-
9李继军,谢海龙,张丽娟.肝癌病人行介入治疗的护理体会[J].吉林医学,2005,26(11):1174-1174.
-
10饮食疗法、临床营养学[J].国外科技资料目录(医药卫生),1998(7):35-35.